| Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment A Imran, L Jooyun, G Areum, C Gildon, L Kwangho Bioorganic & Medicinal Chemistry Letters, 2017 | 31 | 2017 |
| BET inhibitors as anticancer agents: A patent review I Ali, G Choi, K Lee Recent Patents on Anti-Cancer Drug Discovery 12 (4), 340-364, 2017 | 27 | 2017 |
| Discovery of a new sulfonamide hepatitis B capsid assembly modulator HG Na, A Imran, K Kim, HS Han, YJ Lee, MJ Kim, CS Yun, YS Jung, ... ACS Medicinal Chemistry Letters 11 (2), 166-171, 2020 | 17 | 2020 |
| ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment HJ Lee, M Latif, H Choe, I Ali, HK Lee, EH Yang, JI Yun, CH Chae, ... Archives of Pharmacal Research 37, 1130-1138, 2014 | 13 | 2014 |
| Sulfamoylbenzamide-based capsid assembly modulators for selective inhibition of hepatitis B viral replication YH Lee, HM Cha, JY Hwang, SY Park, AG Vishakantegowda, A Imran, ... ACS Medicinal Chemistry Letters 12 (2), 242-248, 2021 | 12 | 2021 |
| Identification of TRD‐35 as Potent and Selective DRAK2 Inhibitor I Ali, S Park, ME Jung, N Lee, M Bibi, CH Chae, KM Yang, SJ Kim, G Choi, ... Bulletin of the Korean Chemical Society, 2020 | 10 | 2020 |
| Abstract LBA009: Orally available ENPP1 inhibitor, TXN10128, restores STING activation in tumor microenvironment and confers anti-tumor responses in combination with immune … S Kim, I Ali, A Yu, SW Lee, S Park, JH Choi, Y Park, C Park Molecular Cancer Therapeutics 20 (12_Supplement), LBA009-LBA009, 2021 | 8 | 2021 |
| P120 BBT-401 Is a Selective Pellino-1 Protein-Protein Interaction Inhibitor in Clinical Development Targeting a First-In-Class Drug for UC Treatment G Lee, YS Lee, M Chang, SUK Kang, JH Ryou, JJ Lim, A Imran, SH Park, ... Gastroenterology 156 (3), S82, 2019 | 4 | 2019 |
| Pyrrolidine Carboxamido Derivatives and Methods for Preparing and Using the Same K Lee, SD Rhee, G Choi, I Ali, CH Chae, MK Jeon, SJ Park, YS Lee US Patent US2,017,008,924, 2017 | 3 | 2017 |
| DW71177: A novel [1, 2, 4] triazolo [4, 3-a] quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia I Ali, HJ Cha, B Lim, CH Chae, J Youm, WJ Park, SH Lee, JH Kim, ... European Journal of Medicinal Chemistry 265, 116052, 2024 | 1 | 2024 |
| Novel naphthyridinone derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase and use thereof SJ Han, CS Park, SJ Kim, JE Cheong, JH Choi, A Imran, SW Lee, YY Park, ... US Patent App. 18/269,609, 2024 | | 2024 |
| Novel benzotriazole derivative having inhibitory activity against ectonucleotide pyrophosphatase-phosphodiesterase, and use thereof CS Park, SJ Kim, A Imran, YJ Na, SR Paik, JH Choi, SW Lee, YY Park, ... US Patent App. 18/274,867, 2024 | | 2024 |
| Novel [1, 2, 4] Triazolo [4, 3-a] Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases … K Lee, G Choi, I Ali, JY Lee, JS Lee, WJ Park, YT Kim, SH Kim, JH Kim, ... US Patent App. 16/480,908, 2020 | | 2020 |
| BBT-401 IS A SELECTIVE PELLINO-1 PROTEIN-PROTEIN INTERACTION INHIBITOR IN CLINICAL DEVELOPMENT TARGETING A FIRST-IN-CLASS DRUG FOR UC TREATMENT. G Lee, YS Lee, M Chang, SUK Kang, JH Ryou, JJ Lim, A Imran, SH Park, ... INFLAMMATORY BOWEL DISEASES 25, S58-S58, 2019 | | 2019 |
| Pyrrolidine carboxamido derivatives and methods for preparing and using the same G Choi, S Dal RHEE, I Ali, C Hak CHAE, SH Park, M Kook JEON, ... WO Patent WO2,017,008,033, 2017 | | 2017 |
| Discovery of BET bromodomain inhibitors with novel scaffolds and its application to treat cancers H Kim, A Imran, K Lee, G Choi FEBS JOURNAL 283, 259-259, 2016 | | 2016 |
| Ketonepeptide derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory diseases containing the same as an active … R Sangdal, C Gildon, I Ali, L Kwangho KR Patent 1,020,160,052,892, 2016 | | 2016 |
| peptide derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory diseases containing the same as an active ingredient L Kwangho, ALI Imran, RS Dal, CG don, JM Kook, CC Hak, AHNS Hoon, ... KR Patent 1,016,006,130,000, 2016 | | 2016 |
| Design, Synthesis, and Evaluation of 2-Anilino-4-(3, 5-dicarboxamidespiperidine)-pyrimidines as Anaplastic Lymphoma Kinase Inhibitors. M Latif, S Park, I Ali, H Choe, CH Chae, CH Park, HR Kim, CS Yun, K Lee Bulletin of the Korean Chemical Society 36 (9), 2015 | | 2015 |
Hyo Gyeong NaDuke UniversityVerified email at duke.edu
Hyo Gyeong NaDuke UniversityVerified email at duke.edu